Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medlive Technology Co's Enterprise Value is HK$720.7 Mil.
Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil. Therefore, Medlive Technology Co's EV-to-EBIT ratio for today is 2.60.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medlive Technology Co's Enterprise Value is HK$720.7 Mil.
Medlive Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$287.5 Mil. Therefore, Medlive Technology Co's EV-to-EBITDA ratio for today is 2.51.
Medlive Technology Co Enterprise Value Historical Data
The historical data trend for Medlive Technology Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medlive Technology Co's Enterprise Value
For the Medical Distribution subindustry, Medlive Technology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co's Enterprise Value Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's Enterprise Value falls into.
Medlive Technology Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medlive Technology Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medlive Technology Co's current Enterprise Value is HK$720.7 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$277.3 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medlive Technology Co's EV-to-EBITDA for today is:
Medlive Technology Co's current Enterprise Value is HK$720.7 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$287.5 Mil.
Medlive Technology Co's current Enterprise Value is HK$720.7 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$450.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Medlive Technology Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Medlive Technology Co (HKSE:02192) Business Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02192 has been successfully added to your 